Objective. To examine rates of readmission after parathyroidectomy in patients with chronic kidney disease and determine primary etiologies, timing, and risk factors for these unplanned readmissions.
parathyroid adenoma, but diffuse parathyroid gland hyperplasia, carcinoma, and familial endocrine disorders are other potential etiologies. SHPT is characterized by elevated PTH levels and parathyroid gland hyperplasia as a physiological response to a chronically hypocalcemic state. SHPT is most commonly associated with chronic kidney disease (CKD), although it can be seen in malabsorption states. In CKD, declining renal function results in impaired mineral homeostasis-namely, hyperphosphatemia and decreased production of active 1,25-dihydroxyvitamin D, which together lead to precipitation of insoluble calcium phosphate and decreased intestinal calcium absorption. 3 In response to the hypocalcemic sate, elevations in PTH occur early in the course of CKD and worsen as renal function further declines. 4 Tertiary hyperparathyroidism refers to the state of excess PTH secretion and hypercalcemia associated with longstanding SHPT; the term is sometimes reserved for hyperparathyroidism that persists after renal transplantation. 5, 6 Primary hyperparathyroidism is classically thought of as a surgical disease, with surgery indicated for symptomatic patients or those at risk of developing complications of hyperparathyroidism. Although medical management is possible, it is more commonly employed for poor surgical candidates or for management of SHPT. Medical management of SHPT has improved, notably with the 2004 approval of the calcimimetic medication cinacalcet, yet rates of parathyroidectomy for refractory SHPT in the United States have not declined substantially in patients with CKD. 2 Due to the complex interaction between the parathyroid glands and the renal function of patients with CKD, patients with SHPT are at increased risk for endocrine and electrolyte derangements in the postoperative period and therefore more likely to be admitted for observation after surgery. 7, 8 Previous studies using the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database have found that preoperative hemodialysis and renal impairment are both risk factors for readmission after parathyroidectomy, with readmission rates of 2.9% to 3.8%. 9, 10 Unplanned readmissions are a significant burden for patients as well as the health care system. Thirty-day readmission rate is considered a quality metric upon which hospitals are graded and compared by the Centers for Medicare & Medicaid Services (CMS). 11 In general, patients with CKD have higher rates of hospital readmissions than the general population after any hospitalization. Patients with CKD stage V, or end-stage renal disease (ESRD), have nearly double the 30-day readmission rate compared with the general population. [12] [13] [14] Readmission in the ESRD population has recently come under scrutiny by the CMS, and consequently, CMS has rolled out the ESRD Quality Incentive Program, which penalizes dialysis centers and hospitals with hemodialysis units for higher than expected unplanned 30-day readmissions. 15 In addition, the Hospital Readmissions Reduction Program, which penalizes hospital reimbursements for excess readmissions, is expected to expand its list of surgical procedures. 16 With the reduction of unplanned readmissions being critically important to the national health care system, it is imperative to understand the epidemiology of readmissions, especially in high-risk populations. In this study, we examine rates of readmission in patients with CKD undergoing parathyroidectomy, determine the primary causes and timing of unplanned readmissions, and identify risk factors for readmission.
Methods

Study Data Source
A retrospective cohort study was performed using the 2013 Nationwide Readmissions Database (NRD) of the Healthcare Cost and Utilization Project (HCUP) from the Agency for Healthcare Research and Quality (AHRQ). HCUP is a group of health care databases with data representing approximately 97% of all inpatient hospital discharges in the United States. The 2013 NRD samples from 21 geographically dispersed states, accounting for 49.1% of all US hospitalizations, and contains data from over 14 million hospital admissions, estimated to represent over 35 million discharges nationally. Patients included in the NRD have unique linkage numbers that allow investigators to track admissions across hospitals. For each hospital stay, the NRD contains demographics, diagnoses, procedures, hospital characteristics, length of stay, charges for hospitalization, severity, and comorbidity measures, in addition to other clinical and nonclinical data. 16 
Study Population and Design
We queried the 2013 NRD using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) procedure codes 06.81 (complete parathyroidectomy) and 06.89 (other parathyroidectomy) to identify index admissions with parathyroidectomy. Only admissions for patients with diagnosis codes indicating CKD (see Supplemental Table S1 , available in the online version of the article) were included. 2 We excluded patients younger than 18 and those who were pregnant, receiving chemotherapy, or diagnosed with malignant thyroid or parathyroid neoplasms. In addition, we excluded patients who died during their index hospitalization and those with a same-day readmission, since this could be considered a continuation of the index admission or a transfer to another institution. Patients admitted for parathyroidectomy in December were also excluded because of inadequate follow-up time (see Supplemental Figure S1 , available in the online version of the article).
Definition of Index Admission and Readmission
Index admissions were defined as hospitalizations during which the patient underwent a complete or partial parathyroidectomy. Readmissions were identified as any nonelective admission occurring within 30 days of an index admission. Patients could have more than 1 readmission in the 30-day period after surgery; however, comparisons of baseline characteristics and modeling predictors of readmissions were done at the index admission level only. Primary diagnoses for readmissions were defined by ICD-9-CM codes. For given time intervals, we reported the top 5 reasons for readmission.
Definition of Covariates
Risk adjustment factors included demographics (age, sex, household income category by ZIP code), primary payer (Medicaid, Medicare, private, self-pay, no charge, or others), and index admission characteristics (admission source, elective vs nonelective, hospital size, hospital type, hospital control, length of stay, and discharge disposition). Discharge disposition was categorized as routine (defined as home or self-care), discharge to skilled nursing facility, discharge with home health care, or against medical advice (AMA).
Knowing that comorbid conditions affect risk of readmission, we adjusted using 12 AHRQ-defined comorbidity measures (weight loss/malnutrition, coagulopathy, ESRD, congestive heart failure, depression, peripheral vascular disease, chronic pulmonary disease, obesity, anemia, diabetes mellitus, neurologic disease, and hypertension). These were assigned using software that identifies ICD-9 coded comorbidities in hospital discharge records and groups them into clinically relevant categories. 17 In addition to these comorbidities, we also adjusted for implant or graft complications, coronary artery disease, and hypocalcemia using their respective Clinical Classification Software (CCS) or ICD-9-CM codes. 18 We used validated All Patient Refined Diagnosis-Related Groups (APR-DRG) scores to account for disease severity. 19 Indications for index parathyroidectomy were categorized into primary hyperparathyroidism, SHPT, or other indications. The ''other indications'' category contains ICD-9 codes for a variety of conditions, which includes unspecified hyperparathyroidism, other hyperparathyroidism, benign thyroid neoplasm, nontoxic multinodular goiter, and other less common diagnoses.
Statistical Analysis
We compared baseline characteristics for patients with and without a 30-day readmission. Chi-square test was used to compare categorical variables, and Kruskal-Wallis tests were used for continuous variables.
The NRD is a complex health survey that implements stratification and clustering to provide discharge weights that can be used to generate national estimates. We used survey logistic regression, a regression technique for survey sample designs, to identify predictors of unplanned 30-day readmission for this unequally weighted data set. 20 Logistic regression was adjusted for demographics, comorbidities, and admission and hospital characteristics. Results of the multivariable logistic regression are reported as adjusted odds ratios (aORs) and 95% confidence intervals (CIs) for each covariate in the model.
All analyses were performed using R version 3.3.0 (R Foundation for Statistical Computing, Vienna, Austria). We considered 2-tailed P values .05 as statistically significant. This study was determined to be exempt by the institutional review board of Mount Sinai Hospital.
Results
Parathyroid Procedures and Readmission
A total of 2756 inpatient parathyroidectomies were performed in patients with CKD in the United States in 2013, accounting for approximately one-third of all inpatient parathyroidectomies performed that year. The indications for these procedures were SHPT (50%), primary hyperparathyroidism (22%), and unspecified hyperparathyroidism (13.5%). Of these, 475 (17.2%) had at least 1 unplanned readmission within 30 days, and 65 (2.4%) had more than 1 readmission. Patients who underwent surgery for primary and secondary hyperparathyroidism had readmission rates of 11.8% and 17.3%, respectively.
Baseline Characteristics
Patient characteristics at index admission were compared for patients with no readmissions and those with 1 readmission. In general, patients were similar with respect to age, sex, comorbid conditions, and income. However, readmitted patients were significantly more likely to have a concurrent diagnosis of congestive heart failure (17.5% vs 10.8%; P = .02) and weight loss/malnutrition (7.9% vs 2.3%; P \ .001). In addition, readmitted patients had higher scores on the APR-DRG Severity Scale (major/extreme loss of function, 43.1% vs 34.8%; P = .002) and APR-DRG Risk of Mortality Scale (major/extreme likelihood of dying, 23.5% vs 13.9%; P = .001). There was also a trend toward more coagulation disorders (6.5% vs 3.2%; P = .06) and diabetic complications (16.3% vs 10.8%; P = .06) for patients with unplanned readmissions. With respect to indication for parathyroidectomy, approximately 50% of total readmissions were seen in patients being treated for SHPT ( Table 1) .
Regarding index admission characteristics, readmitted patients were more likely to have been admitted from the emergency department (20.1% vs 11.9%; P = .005) and to have a nonelective index admission (34.6% vs 22.3%; P = .001). Readmitted patients had longer lengths of stay (LOS) during the index admission (median, 5 days vs 4 days; P \ .001), lower proportion of routine discharges (75.5% vs 87.6%; P \ .001), and higher costs of index hospitalization ($15,424 vs $12,005; P \ .001). Hospital characteristics, including bed size, teaching status, ownership/control, and urban-rural designation, were similar for patients with and without readmissions ( Table 2 ).
Etiology and Timing of Readmission
Readmissions occurred uniformly throughout the 30 days after parathyroidectomy with 33.6%, 35.5%, and 30.9% of readmissions occurring from days 1 to 10, 11 to 20, and 21 to 30 after discharge, respectively ( Figure 1) . However, readmission for hypocalcemia/hungry bone syndrome decreased throughout the 30 days with these conditions, accounting for 40.0%, 28.3%, and 25.1% (P = .014) of readmissions at 1 to 10, 11 to 20, and 21 to 30 days after discharge, respectively ( Figure 2 ). Detailed representation of these data, as well as the most common other reasons for readmission, are depicted in graphical form in Figure 3 . Common complications of surgical procedures only accounted for 2.5% of readmissions in the entire 30-day window after discharge.
Predictors of Unplanned 30-Day Readmission
Few patient-specific predictors of unplanned 30-day readmission in patients with CKD were identified with survey logistic regression. Weight loss/malnutrition and length of Table 3 and Table 4 ).
Discussion
Using a nationally representative cohort of patients with CKD, we found that nearly one-fifth of patients were readmitted within 30 days of parathyroidectomy, with some experiencing multiple readmissions within those 30 days. Weight loss/malnutrition, parathyroidectomy for SHPT or other indications, and hospital length of stay 5 to 6 days after parathyroidectomy were predictive of 30-day readmission in this population. Readmissions occurred uniformly throughout the 30 days after discharge; however, readmissions for hypocalcemia typically occurred earlier and decreased with time.
We found that the rate of readmissions after parathyroidectomy in patients with CKD is nearly 5-fold higher than the rate found in nonpatients with CKD who underwent parathyroidectomy. 9,10 Unsurprisingly, patients with ESRD on hemodialysis have higher readmission rates, 23.8%, due to their multimorbidity. 12, 21 The comorbidity measure for weight loss, which includes ICD-9-CM codes for malnutrition, loss of weight, and low body weight, was the only patient-specific predictor for unplanned 30-day readmission in this cohort. This finding is consistent with previously published NSQIP data, which cite malnutrition as a predictor for readmission after thyroidectomy and parathyroidectomy. 9 We also observed that postparathyroidectomy hospital length of stay for 5 to 6 days was associated with increased risk of 30-day readmission. Length of stay greater than 1 day was previously identified as a predictor of readmission in the general population. 9,10 Hospital length of stay greater than 7 days did not predict readmission in the regression analysis, likely because the increased comorbidity burden in these patients displaced the risk that could be attributed to length of stay. While it did not reach statistical significance, ESRD trended toward being a predictor of 30-day readmission, again agreeing with prior literature. 9, 10 The trend toward increased readmissions for patients discharged to skilled nursing facilities may be a reflection of baseline debilitation in these patients. Alternatively, this finding may suggest a possible communication breakdown that occurs when patients are discharged to these facilities. Compared with readmission rates for parathyroidectomies performed for primary hyperparathyroidism, those performed for SHPT and other indications had greater risk of readmission. Primary hyperparathyroidism and SHPT represent different disease mechanisms, with primary hyperparathyroidism arising from adenomas and SHPT due to CKD. In contrast to primary hyperparathyroidism, with surgery as the mainstay, SHPT can be managed medically, with parathyroidectomy only indicated in late stages. Thus, it is expected that patients with SHPT would have a greater comorbidity burden at the time of parathyroidectomy and are prone to readmission. Patients undergoing parathyroidectomy for other indications may also have more comorbidity burden, but it is not possible to identify a specific reason for readmission with the variety of indications.
Readmissions occurred uniformly over the course of the 30 days after discharge, but the etiologies for readmission changed with time. Hypocalcemia/hungry bone syndrome was the most common reason for unplanned 30-day readmission, accounting for 31.2% of readmissions. These rates were comparable to the 36% identified in a recent NSQIP study. 10 Hypocalcemia and hungry bone syndrome commonly occur after parathyroidectomy due to the abrupt reduction in PTH at surgery, which results in increased bone formation and decreased bone resorption. Although we found a peak in readmissions for hypocalcemia/hungry bone syndrome in the first 10 days after discharge, this is a serious complication that should be monitored for days to weeks after surgery.
The results of our study highlight areas for improvement in reducing readmissions. While we have not tested any specific interventions, thorough literature review reveals several strategies. Of utmost importance is careful attention to medication reconciliation. 22, 23 Given the high rates of polypharmacy and elevated risk of adverse drug reactions in patients with CKD, careful review of all medications and appropriate discontinuation of medications like cinacalcet are necessary after parathyroidectomy. 12, 24 Furthermore, patients should be educated about hypocalcemic symptoms and the importance of adherence to calcium and vitamin D supplementation. Since hypocalcemia readmissions tend to occur more frequently in the early postoperative period, providers should consider earlier prescriptions of calcium/vitamin D supplements, either at the preoperative visit or at least 24 hours before discharge, allowing adequate time for patients to acquire these critical medications. Where available, efforts should be made to have medications delivered to the patient prior to discharge. 25 In addition, patients with CKD may benefit from endocrine consult services during their hospital admission, as their calcium demands may exceed those of patients without CKD and should be optimized predischarge. 26, 27 For dialysis patients or patients who are discharged to skilled nursing facilities, appropriate communication with these outside facilities is critical. Miscommunication during transitions of care is an important risk factor for adverse events, with omission of ordered medications occurring most frequently. [28] [29] [30] These patients may benefit from increased outpatient nephrology involvement as they can monitor for and intervene on complications. 31 Appropriate communication between hospitals and outpatient dialysis units may allow providers to make necessary adjustments. Last, given the level of complexity in patients with CKD, it may be beneficial to have a multidisciplinary outpatient approach to reduce readmissions.
As with many retrospective database studies, the use of administrative data does not allow us to capture factors, including race, not coded in patient discharge summaries. In addition, we rely on the accuracy of ICD-9 codes, which can be variable in administrative databases. Excellent outcomes in many endocrine surgeries have encouraged outpatient parathyroidectomy with same-day discharge for eligible patients, but the NRD database only includes patients with an inpatient hospital stay. We cannot rule out the possibility that some healthier patients with CKD had outpatient surgery and therefore were not captured in this analysis. However, it is reassuring to note that our sample size does roughly agree with a recent publication evaluating national trends in parathyroidectomy. 2 Finally, we could not capture patients who died outside of the hospital within 30 days.
The major strength of our study lies in the nationally representative sample size and the ability to track interhospital readmissions within the same state. To our knowledge, this is the first study to examine readmission rates after parathyroidectomy in this clinically and economically important population.
Conclusion
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